Subscribe
Healthcare

Moderna requests authorization for COVID-19 vaccine for children under 6

By Cassidy Morrison
Published
Add Washington Examiner on Google
Moderna requests authorization for COVID-19 vaccine for children under 6

Moderna announced it would request authorization from the Food and Drug Administration to administer a smaller dose of its COVID-19 vaccine to children ages 6 months old to 6 years old.

Clinical trial data showed that children under 6 mounted a robust neutralizing antibody response comparable to young adults when given a dose a quarter as strong, the company said on Wednesday.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Centers for Disease Control and Prevention COVID-19 FDA Pfizer Vaccines